信立泰(002294.SZ):捐贈200萬元藥品及醫護用品用於支持疫情防控
格隆匯2月4日丨信立泰(002294.SZ)公佈,當下,新型冠狀病毒感染引發的肺炎疫情不斷蔓延。公司高度關注疫情發展,在積極做好企業疫情防控的同時,切實履行上市公司社會責任,通過深圳市慈善會向疫區捐贈價值200萬元的藥品及醫療保護用品,包括抗感染藥物注射用頭孢曲松鈉(信達靜®)、注射用頭孢呋辛鈉(信立欣),以支援武漢地區做好新型冠狀病毒感染的肺炎疫情防控工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.